12, 1, Zhejiang province started the nine-valent human papillomavirus vaccine, and all women aged 9-45 in our province can be vaccinated with the nine-valent HPV vaccine!
The development of school-age vaccination means that women aged 9- 15 and 27-45 in Zhejiang province can also choose the nine-valent HPV vaccine to help women of more ages stay away from diseases related to human papillomavirus infection, including cervical cancer, and support the umbrella of primary prevention of female cervical cancer.
Zhenhai district HPV vaccine appointment vaccination is the responsibility of the local community service center. For details, please consult the vaccination clinic of community health service center or the vaccination clinic of Zhenhai Second Hospital. If necessary, please call the following number for consultation:
Source: Zhenhai CDC
I. Nine-valent HPV vaccine cannot be reserved at present. Can it wait until the vaccine is sufficient?
A: It is not recommended to miss the vaccination opportunity of the nine-valent HPV vaccine.
In recent years, there has been a phenomenon of "one vaccine is hard to find" in China, especially the nine-valent vaccine for more kinds of human papillomavirus. According to the knowledge of many public health experts, the earlier the HPV vaccine is vaccinated, the better, especially for adult women who have already had sex. It is not recommended to wait for the nine-valent HPV vaccine, because there is a risk of human papillomavirus infection.
From the level and diversity of prevention, it is best to play with nine prices, but there are not so many nine prices, and many people can't rank. If you insist on waiting, you are likely to be infected while waiting. Adolescents vaccinated with HPV vaccine have better protection effect, so it is recommended to vaccinate as soon as possible.
Second, what changes have been made in the composition and vaccination procedures of the nine-valent HPV vaccine during this age expansion?
A: No.
The nine-valent vaccines are all the same, and the ingredients of the vaccines are the same. They have not changed before. The vaccination procedure of the vaccine has not changed, and it is still necessary to take three shots and vaccinate at 0, 2 and 6 months respectively.
3. What kinds of human papillomavirus vaccines are available on the market at present, and what are the differences between them?
A: At present, in China, women aged 9-45 can be vaccinated with bivalent, tetravalent and nonavalent HPV vaccines. The bivalent and tetravalent vaccines can prevent about 70% of cervical cancer, and the nine-valent vaccine can prevent 92% of cervical cancer.
4. The whole process has been vaccinated with bivalent or tetravalent vaccine. Can I get another nine-valent vaccine?
A: The instructions for the nine-valent HPV vaccine point out that if you want to vaccinate the nine-valent HPV vaccine after three doses of the four-valent HPV vaccine, it will take at least 12 months to start vaccination, and the vaccination dose is three times. As for the bivalence of vaccination, there is a lack of some clinical data to support bivalence of vaccination, so it is impossible to make relevant suggestions. For those who are being vaccinated with bivalent or tetravalent vaccines, due to the recommendations in the WHO position paper, the relevant research data on the safety and immune effect of the three human papillomavirus vaccines are very limited, and these vaccines are different in characteristics, components and indications, so it is not recommended to exchange vaccinations within their respective immunization plans.
5. Is it still useful to get married or have a baby to get HPV vaccine?
A: Useful.
The primary target population of human papillomavirus vaccination recommended by the World Health Organization is girls aged 9~ 14 who have no sexual history. However, even women who have had sex, married and have children can still get HPV vaccine, and they can also get good protection effect.
6. If I am infected with human papillomavirus, can I be vaccinated?
A: Yes.
Vaccination with HPV vaccine can prevent infection of other human papillomavirus types or reinfection of the same human papillomavirus type, thus avoiding persistent infection and recurrence. However, it will not have any therapeutic effect on the existing human papillomavirus infection and related diseases, nor can it prevent the development of diseases. Therefore, there is no need to have a once-and-for-all attitude, and cervical cancer screening should be conducted regularly.